← Leaderboards
Robin Patel
Mayo Clinic Rochester
$12,478,550
Attributed
$16,386,179
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,386,179 · 11
By mechanism
R01$14,268,042 · 5
R21$1,712,312 · 4
R03$211,650 · 1
R41$194,175 · 1
Top collaborators
- Haluk Beyenal9 shared
- Vincent M. Rotello9 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionBacteriaMicrobial BiofilmsIn VitroIn VivoAntimicrobialMicroorganismStaphylococcus AureusAntibioticsTissuesBaseToxic EffectResistancePreventionPseudomonas AeruginosaSurfaceLaboratoriesOperative Surgical ProceduresBacterial InfectionsOrthopedicsDevicesImplantPreventCells
Grant awards (46)
Novel Electrochemical Bandage for Treatment of Wound Infections$661,948
R01 · FY2025 · AI · contact PI
Phage-Polymer Nanoparticles for Treatment of Antibiotic-Recalcitrant Wound Biofilm Infections$593,860
R01 · FY2025 · AI
Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection$382,186
R01 · FY2025 · HL · contact PI
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections$377,135
R01 · FY2025 · AI
Novel Electrochemical Bandage for Treatment of Wound Infections$424,176
R01 · FY2024 · AI · contact PI
Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection$382,186
R01 · FY2024 · HL · contact PI
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections$377,555
R01 · FY2024 · AI
Proteomic Analysis of Implant Surfaces in Athroplasty Failure$198,750
R21 · FY2024 · AI · contact PI
Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection$395,436
R01 · FY2023 · HL · contact PI
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections$377,967
R01 · FY2023 · AI
Proteomic Analysis of Implant Surfaces in Athroplasty Failure$238,500
R21 · FY2023 · AI · contact PI
Novel Electrochemical Bandage for Treatment of Wound Infections$468,744
R01 · FY2022 · AI · contact PI
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections$393,246
R01 · FY2022 · AI
Novel Electrochemical Bandage for Treatment of Wound Infections$464,963
R01 · FY2021 · AI · contact PI
Crosslinked Nanosponges for the Topical Treatment of Wound Biofilms$387,690
R01 · FY2021 · AI
Ureaplasma urealyticum- and Ureaplasma parvum-associated hyperammonemia$238,500
R21 · FY2021 · AI · contact PI
Metagenomic Analysis of Arthroplasty Failure$534,359
R01 · FY2020 · AR · contact PI
Novel Electrochemical Bandage for Treatment of Wound Infections$464,885
R01 · FY2020 · AI · contact PI
Crosslinked Nanosponges for the Topical Treatment of Wound Biofilms$395,539
R01 · FY2020 · AI
Ureaplasma urealyticum- and Ureaplasma parvum-associated hyperammonemia$198,750
R21 · FY2020 · AI · contact PI
Novel Electrochemical Bandage for Treatment of Wound Infections$479,443
R01 · FY2019 · AI · contact PI
Crosslinked Nanosponges for the Topical Treatment of Wound Biofilms$397,710
R01 · FY2019 · AI
Metagenomic Analysis of Arthroplasty Failure$534,359
R01 · FY2018 · AR · contact PI
Crosslinked Nanosponges for the Topical Treatment of Wound Biofilms$390,589
R01 · FY2018 · AI
Metagenomic Analysis of Arthroplasty Failure$785,802
R01 · FY2017 · AR · contact PI
Disappearance of rifampin resistance in MRSA foreign body osteomyelitis$238,500
R21 · FY2017 · AI · contact PI
Metagenomic Analysis of Arthroplasty Failure$547,302
R01 · FY2016 · AR · contact PI
Metagenomic Analysis of Arthroplasty Failure$238,500
R01 · FY2016 · AR · contact PI
Disappearance of rifampin resistance in MRSA foreign body osteomyelitis$198,750
R21 · FY2016 · AI · contact PI
Metagenomic Analysis of Arthroplasty Failure$547,302
R01 · FY2015 · AR · contact PI
The Electricidal Effect, a Novel Anti-Biofilm Strategy$394,250
R01 · FY2015 · AI · contact PI
The Electricidal Effect, a Novel Anti-Biofilm Strategy$394,250
R01 · FY2014 · AI · contact PI
The Electricidal Effect, a Novel Anti-Biofilm Strategy$370,279
R01 · FY2013 · AI · contact PI
Molecular Detection of Biofilms on Hip and Knee Implants$245,565
R01 · FY2013 · AR · contact PI
The Electricidal Effect, a Novel Anti-Biofilm Strategy$408,346
R01 · FY2012 · AI · contact PI
Molecular Detection of Biofilms on Hip and Knee Implants$258,490
R01 · FY2012 · AR · contact PI
The Electricidal Effect, a Novel Anti-Biofilm Strategy$394,250
R01 · FY2011 · AI · contact PI
Molecular Detection of Biofilms on Hip and Knee Implants$258,490
R01 · FY2011 · AR · contact PI
Molecular Detection of Biofilms on Hip and Knee Implants$269,260
R01 · FY2010 · AR · contact PI
Molecular Detection of Biofilms on Hip and Knee Implants$271,980
R01 · FY2009 · AR · contact PI
Detection of Biofilm Bacteria using GloBac$194,175
R41 · FY2008 · AR · contact PI
Enhancement of antimicrobics by electrical current$215,562
R21 · FY2007 · AI · contact PI
Enhancement of antimicrobics by electrical current$185,000
R21 · FY2006 · AI · contact PI
HUMAN RETROVIRUS-5 AND ARTHRITIS$70,550
R03 · FY2002 · AR
HUMAN RETROVIRUS-5 AND ARTHRITIS$70,550
R03 · FY2001 · AR
HUMAN RETROVIRUS-5 AND ARTHRITIS$70,550
R03 · FY2000 · AR